The United States has seen its share of generic drug failures.
There are also more generic drug-makers than ever, and more generics are being introduced to market.
But the majority of these products are coming from generics companies, not generic drug manufacturers.
These companies are making the generic versions, and they’re doing so at a profit.
Nowhere are this profit-taking patterns more evident than in the U.S. pharmacy industry.
The pharma industry has been in a downward spiral for a decade, and for the first time in more than a decade we’re starting to see some progress in the industry.